The Genentech Patient Foundation provides free access to Genentech medicines for eligible U.S. patients facing financial or insurance barriers, supporting equitable access to innovative therapies.
Funder: Roche
Due Dates: Rolling (applications accepted year-round)
Funding Amounts: Free Genentech medicines for eligible patients; coverage duration as long as eligibility is maintained.
Summary: Provides free Genentech medicines to eligible U.S. patients facing insurance or financial barriers.
Key Information: Both patient and prescriber forms are required; U.S. residency and treatment by a U.S.-licensed physician are necessary.
The Genentech Patient Foundation offers free access to Genentech medicines for eligible patients who are uninsured, underinsured, or experiencing financial hardship. The program aims to ensure that financial or insurance barriers do not prevent access to necessary, prescribed Genentech treatments. Comprehensive support is provided throughout the application process, including assistance for both patients and healthcare providers. The foundation covers a wide range of Genentech medicines and strives for inclusivity regardless of race, citizenship/immigration status, age, disability, gender identity, or sexual orientation.